Biotechnology

Attomarker is a spin-out company from the University of Exeter, a member of the UK’s Russell Group of research-intensive universities. The company’s founder, Professor Andrew Shaw, leads a team of scientists and engineers across the UK & Germany. Backed by six patents and referenced in 17 academic j

Medication Delivery, Third-Party Administration services, Data Management, Risk-Management

IHPBA was incorporated as a non-profit organization in 1994 with the goal of finding effective treatment for the disorders of the liver, pancreas and biliary tree by improving education, training, innovation, research and patient care. The Association’s aims are as follows: • To promote understandi

Oragenics develops oral probiotic products and antibiotics for humans and companion pets.

At Sandoz, we are discovering new ways to improve and extend people's lives and to make high-quality medicines more accessible to people around the world. While Sandoz holds global leadership in biosimilars, generic antibiotics, dermatology and transplant medicines, it is also a global leader in man

IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients’ quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA develops biophysical treatments in two main areas: - Ort

At HealthLytix, we create data analytics solutions to provide comprehensive insights into health status based on genetics and medical imaging. Our products provide consumers with the benefits of early detection and targeted care, while empowering physicians with more accurate diagnostic decision-mak

Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease, and infectious diseases.

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.

Cytovac is a clinical-stage biopharmaceutical company.

Pioneering a New Era of Precision Medicines to Restore Brain Health and Wellbeing

EnviroZyme believes in the power of microbial solutions to protect people and the planet. We formulate, blend, and package microorganisms capable of breaking down potentially harmful organic compounds to make an impact on personal spaces, the greater environment, and business’s bottom line. Equippe

CarboCode develops sphingolipids that are useful for the operation of the brain, skincare, and the development of babies.

Medorah Meditek Pvt. Ltd., established in 2016 in Gurgaon, develops and manufactures devices to treat an array of medical conditions including diseases pertaining to digestive and pulmonary systems. Common gastrointestinal (GI) disease states include esophageal disorders, GI strictures, and bleeding

Committed to Truth-telling for Early Success in Drug Development

Stellar Development provides software solutions tailored for diverse industries, empowering businesses to thrive in today's dynamic landscape. From cutting-edge technology to strategic insights, we deliver results that drive success across every sector.

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating neurological disorders.

Mill Creek Life Sciences provides tools and technologies to support the development and application of cellular and biologic therapeutics.

Reading between the MRI lines, Darmiyan is revolutionizing brain health, offering decision making tools for Alzheimer's.

BioGaia is an innovative Swedish health care company and a world leader in probiotics.

Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understandi

Polyganics is a medical technology company that develops, manufactures, and markets bioresorbable medical devices.

Herophilus is a neurotherapeutics discovery company bused on next-generation scaled complex in vitro models

Biosortia is modernizing and vastly improving what historically is the most successful approach to drug discovery - a methodology that previously accessed less than 1% we can now effectively open the other 99% to exploration.

GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.

Allied BioScience is dedicated to developing innovative solutions to create cleaner human environments. We specialize in revolutionary, always-on antimicrobial coatings that provide continuous and long-lasting surface protection across public spaces.

Jungbunzlauer is one of the world's leading producers of biodegradable ingredients of natural origin. The Swiss-based, international company's roots date back to 1867. Jungbunzlauer offers a wide range of natural ingredients for food and beverages, healthcare, personal care, cleaners and detergents,

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor

FHI Clinical is a global contract research organization that manages complex research.

Innatrix is an early stage agricultural biotechnology company dedicated to developing and improving sustainable, eco-friendly biopesticides for untreatable crop diseases.

Biosceptre has identified a cancer target, nf-P2X7, present in many cancer types, and importantly not found in healthy tissue.

Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop potentially curative therapies for solid tumor cancers.

Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Lumen's goal is to transform the way such drugs are developed, what they cost, and who has access to them.

VOTIS provides clinical decision assistance for foot ulcers syndrome and associated diseases.

IFOM is a highly technological, non-profit cancer research centre. The research conducted at IFOM aims to understand the molecular processes responsible for the onset and development of cancer. IFOM was established in 1998 by FIRC (the Italian Foundation for Cancer Research). The aim was to create

JP Research is a research company that provides consumer product risk analysis services.

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods.

ASC Therapeutics focuses on the development of curative therapies for rare diseases.

Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis.

Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives.

Life science company focused on solving Duchenne muscular dystrophy

ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther

SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes. Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entir

We invest in advanced technologies from biotech to quantum tech, partnering with companies aligned with our mission of improving the health of people and the planet. We’re a team of deep tech nerds and serial entrepreneurs that backs like-minded founders wanting to change the world. We are the off

Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.

Spun off from SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (SNBL), the largest CRO in Japan, Gemseki Inc. is established to support drug and medical technology development by accelerating pharma licensing. Our Drug Candidate Marketplace is a platform with hundreds of drug candidates and platform techno

Next Frontier Advisors is a scientific consulting firm that delivers strategic advisory services to optimize and advance R&D for improved global health. NFA is built around a network model that harnesses decades of technical and functional expertise from industry and academia. We support commercial

Powered by hypochlorous acid which is produced by our white blood cells for healing. We patented a process for replicating it outside the body in our FDA-registered lab. Works on more than 100 common skin ailments: Sunburns, eczema, cuts, scrapes, zits, scars. Reduce redness, minimize imperfections,

SaniSure is a leading global original equipment manufacturer and supplier of custom, innovative, Single-Use solutions — from R&D to process development to GMP sterile applications. SaniSure can help you design aseptic solutions for transfer, cell growth, sampling, mixing, filling and storage. Use ou